| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.31 | 0.01 |